Although customized intraocular replacements for a damaged iris have been available for some time outside the U.S., it’s only recently that the CustomFlex ArtificialIris, created by HumanOptics in Germany, became the first stand-alone prosthetic iris to receive approval from the U.S. Food and Drug Administration. To date, there’s still no billing code allowing financial reimbursement for implanting the device, but surgeons are nevertheless pleased to have something to offer patients who need an iris prosthesis. In this feature from Review of Ophthalmology, surgeons who have implanted the device share some of their experience and advice. Read More.